Temporary website updates are in progress to fix technical issues. For assistance, visit our Contact Us page.

Bacitracin (as bacitracin methylenedisalicylate) (BACN-M) - Medicating Ingredient Brochure

This page is part of the Guidance Document Repository (GDR).

Looking for related documents?
Search for related documents in the Guidance Document Repository

Status: Veterinary prescription required for approved claims

Revised October 2022

Table of approved species and claims
Approved livestock species Approved claim(s)
(abbreviated) Table Note 1
Withdrawal time Name of approved brand(s)
Laying chickens
  1. Aid in treatment of necrotic enteritis
0 days
  1. BMD 110 G
  2. Bacitracin MD
Broiler chickens
  1. Reduction of early mortality due to diminished feed consumption and chilling
  2. Prevention of necrotic enteritis
  3. Aid in treatment of necrotic enteritis
0 days
  1. BMD 110 G
  2. Bacitracin MD
Pregnant and lactating sows and gilts
  1. Prevention of clostridial enteritis in suckling piglets
0 days
  1. BMD 110 G
  2. Bacitracin MD

Laying hens

Table of approved claims and brands
Approved claims Name of approved brand(s) Drug concentration in DIN product
Claim 1
  1. BMD 110 G
  2. Bacitracin MD
Bacitracin methylenedisalicylate (equivalent to bacitracin) at 110 g/kg

Claim 1

As an aid in treatment of necrotic enteritis associated with Clostridium perfringens susceptible to bacitracin.

Level of medicating ingredient in the complete feed

110 mg/kg (0.011%) of bacitracin (as bacitracin methylenedisalicylate) in the complete feed.

Directions for use in the complete feed

This livestock feed contains a medically important antibiotic. To reduce the development of antimicrobial resistance and maintain effectiveness, use this antibiotic prudently and for the shortest duration required to achieve the desired clinical outcome.

Feed this medicated feed at the first clinical signs of disease. Feed continuously for 7 days.

Additional information (not to appear on feed labels)

For feed manufacturers

Add and thoroughly mix into the ration at the following rate to provide 110 mg/kg (0.011%) bacitracin per metric tonne (1000 kg) of finished (complete) feed:

  • 1.0 kg of the BMD 110 G or Bacitracin MD premixes

Warning

  1. No withdrawal period is required when feeding this medicated feed at the recommended level of 110 mg/kg (0.011%) bacitracin in the complete feed.
  2. No withdrawal period is required for eggs obtained from treated laying hens when feeding this medicated feed at the recommended level of 110 mg/kg (0.011%) of bacitracin in the complete feed.
  3. When handling the product, avoid inhalation, oral exposure and direct contact with skin or eyes. (Required on premix and supplement labels only)
  4. Keep out of reach of children. (Required on premix and supplement labels only)

Caution

  1. Do not use in feeds containing pellet binding agents with the exception of Ameri-Bond 2x (calcium lignosulfonate) and Pel-Stik. (Required on premix and supplement labels only)
  2. Due to known presence of bacitracin-resistant Clostridium perfringens in broiler chickens, use of bacitracin premixes should be based on susceptibility testing. If this is not possible, therapy should be based on clinical judgement and local (regional, farm level) information about susceptibility of the target bacteria.

Accepted compatibilities

Nil

Broiler chickens

Table of approved claims and brands
Approved claims Name of approved brand(s) Drug concentration in DIN product
Claims
1, 2, 3
  1. BMD 110 G
  2. Bacitracin MD
Bacitracin methylenedisalicylate (equivalent to bacitracin) at
110 g/kg

Claim 1

For reduction of early mortality due to diminished feed consumption and chilling.

Level of medicating ingredient in the complete feed

110 mg/kg (0.011%) of bacitracin (as bacitracin methylenedisalicylate) in the complete feed.

Directions for use in the complete feed

This livestock feed contains a medically important antibiotic. To reduce the development of antimicrobial resistance and maintain effectiveness, use this antibiotic prudently and for the shortest duration required to achieve the desired clinical outcome.

Feed this medicated feed to 1 week of age.

Additional information (not to appear on feed labels)

For feed manufacturers

Add and thoroughly mix into the ration at the following rate to provide 110 mg/kg (0.011%) bacitracin per metric tonne (1000 kg) of finished (complete) feed:

  • 1.0 kg of the BMD 110 G or Bacitracin MD premixes

Warning

  1. No withdrawal period is required when feeding this medicated feed at the recommended level of 110 mg/kg (0.011%) bacitracin in the complete feed.
  2. When handling the product, avoid inhalation, oral exposure and direct contact with skin or eyes. (Required on premix and supplement labels only)
  3. Keep out of reach of children. (Required on premix and supplement labels only)

Caution

  1. Do not use in feeds containing pellet binding agents with the exception of Ameri-Bond 2x (calcium lignosulfonate) and Pel-Stik. (Required on premix and supplement labels only)

Claim 2

For prevention of necrotic enteritis caused by Clostridium perfringens susceptible to bacitracin.

Level of medicating ingredient in the complete feed

55 mg/kg (0.0055%) of bacitracin (as bacitracin methylenedisalicylate) in the complete feed.

Directions for use in the complete feed

This livestock feed contains a medically important antibiotic. To reduce the development of antimicrobial resistance and maintain effectiveness, use this antibiotic prudently and for the shortest duration required to achieve the desired clinical outcome.

Feed this medicated feed continuously to market weight.

Additional information (not to appear on feed labels)

For feed manufacturers

Add and thoroughly mix into the ration at the following rate to provide 55 mg/kg (0.0055%) bacitracin per metric tonne (1000 kg) of finished (complete) feed:

  • 0.5 kg (500 g) of the BMD 110 G or Bacitracin MD premixes

Warning

  1. No withdrawal period is required when fed at the recommended level of 55 mg/kg (0.0055%) bacitracin in the complete feed.
  2. When handling the product, avoid inhalation, oral exposure and direct contact with skin or eyes. (Required on premix and supplement labels only)
  3. Keep out of reach of children. (Required on premix and supplement labels only)

Caution

  1. Do not use in feeds containing pellet binding agents with the exception of Ameri-Bond 2x (calcium lignosulfonate) and Pel-Stik. (Required on premix and supplement labels only)

Claim 3

As an aid in treatment of necrotic enteritis associated with Clostridium perfringens susceptible to bacitracin.

Level of medicating ingredient in the complete feed

110 mg/kg (0.011%) of bacitracin (as bacitracin methylenedisalicylate) in the complete feed.

Directions for use in the complete feed

This livestock feed contains a medically important antibiotic. To reduce the development of antimicrobial resistance and maintain effectiveness, use this antibiotic prudently and for the shortest duration required to achieve the desired clinical outcome.

Feed this medicated feed at the first clinical signs of disease. Feed continuously for 7 days.

Additional information (not required to appear on feed labels)

For feed manufacturers

Add and thoroughly mix into the ration at the following rate to provide 110 mg/kg (0.011%) bacitracin per metric tonne (1000 kg) of finished (complete) feed:

  • 1.0 kg of the BMD 110 G or Bacitracin MD premixes

Warning

  1. No withdrawal period is required when feeding this medicated feed at the recommended level of 110 mg/kg (0.011%) bacitracin in the complete feed
  2. When handling the product, avoid inhalation, oral exposure and direct contact with skin or eyes (required on premix and supplement labels only)
  3. Keep out of reach of children (required on premix and supplement labels only)

Caution

  1. Do not use in feeds containing pellet binding agents with the exception of Ameri-Bond 2x (calcium lignosulfonate) and Pel-Stik (required on premix and supplement labels only)
  2. Due to known presence of bacitracin-resistant Clostridium perfringens in broiler chickens, use of bacitracin premixes should be based on susceptibility testing. If this is not possible, therapy should be based on clinical judgement and local (regional, farm level) information about susceptibility of the target bacteria.

Accepted compatibilities

Bacitracin (from bacitracin methylenedisalicylate) is compatible with the following drugs/drug combinations. In cases where there are differences in withdrawal time for the compatible medicating ingredients, the longer withdrawal time is the one that must be used, and is the only one that is to appear on the label of the finished feed. For details, refer to the MIB as indicated.

Bacitracin (broiler chickens)
Name of medicating ingredient MIB code Name of approved brand(s) Applicable claims
Monensin MOS
  1. Coban Premix
  2. Rumensin Premix
  3. Monensin Premix
  4. Monovet Monensin Premix
All claims
Narasin and Nicarbazin NRNC Maxiban Premix All claims
Salinomycin sodium SAL
  1. Coxistac 6% Premix
  2. Coxistac 12% Granular Premix
  3. Posistac 6% Premix
  4. Sacox 120 Medicated Premix
  5. Salinomycin 60 Premix
  6. Bio-Cox 120 G Plus Premix
All claims
Semduramicin sodium (cleared with bacitracin at 55 mg/kg in the complete feed only) SEMD Aviax Medicated Premix 5% All claims
Narasin
(cleared with bacitracin at 55 mg/kg in the complete feed only)
NAR Monteban 100 Premix All claims

Pregnant and lactating sows and gilts

Table of approved claims and brands
Approved claims Name of approved brand(s) Drug concentration in DIN product
Claim 1
  1. BMD 110 G
  2. Bacitracin MD
Bacitracin methylenedisalicylate (equivalent to bacitracin) at 110 g/kg

Claim 1

For prevention of clostridial enteritis in suckling piglets caused by Clostridium spp. susceptible to bacitracin (Clostridial enteritis in piglets has a low incidence in Canada).

Level of medicating ingredient in the complete feed

275 mg/kg (0.0275%) of bacitracin (as bacitracin methylenedisalicylate) in the complete feed.

Directions for use in the complete feed

This livestock feed contains a medically important antibiotic. To reduce the development of antimicrobial resistance and maintain effectiveness, use this antibiotic prudently and for the shortest duration required to achieve the desired clinical outcome.

Feed this medicated feed continuously for 2.5 weeks before farrowing through 3 weeks after farrowing.

Additional information (not to appear on feed labels)

For feed manufacturers

Add and thoroughly mix into the ration at the following rate to provide 275 mg/kg (0.0275%) bacitracin per metric tonne (1000 kg) of finished (complete) feed:

  • 2.5 kg of the Bacitracin MD or the BMD 110 G premixes

Warning

  1. No withdrawal period is required when feeding this medicated feed at the recommended level of 275 mg/kg (0.0275%) bacitracin in the complete feed.
  2. When handling the product, avoid inhalation, oral exposure and direct contact with skin or eyes. (Required on premix and supplement labels only)
  3. Keep out of reach of children. (Required on premix and supplement labels only)

Caution

  1. Do not use in feeds containing pellet binding agents with the exception of Ameri-Bond 2x (calcium lignosulfonate) and Pel-Stik. (Required on premix and supplement labels only)

Accepted compatibilities

Nil